PATENT CLAIM ANALYSIS

Application Number: 15742889
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-12
Patent Classification: ["514", "406000"]

Abstract:
The present invention provides 5-(5-(2-(3-aminopropoxy)-6-methoxyphenyl)-1H-pyrazol-3-ylamino)pyrazine˜2˜carbonitrile and pharmaceutically acceptable salts and solvates thereof that is capable of inhibiting CHK1 and is useful in the treatment of neuroblastomas and/or soft tissue sarcomas.

Claim (Index 10):
The method according to  claim 1 , wherein the compound is 5-(5-(2-(3-aminopropoxy)-6-methoxyphenyl)-1H-pyrazol-3-ylamino)pyrazine-2-carbonitrile.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 86.0
- Lexical Diversity: 1.26471
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12634725', '15513185', '15118072', '14402198', '11919173']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7568552280205955
- 35 USC 102 Novelty (BERT): 0.553961364612451
- Combined Prediction Score: 0.736565841679781
- Mean Citation Score: 303.550176
- Max Citation Score: 394.67114
- Similarity Product: 371.4879612287259

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test